Anika Therapeutics Inc

Healthcare · Drug Manufacturers - Specialty & Generic

19.60$ +1.8% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Anika Therapeutics Inc (ANIK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 183 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANIK
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	231	240	247	265	273	283	284	265	269	279	307	287	320	331	399	441	416	366	362	363	353	348	342	354	348	349	339	329	328	271	264	263	231	203	191	188	189	190	179	183
Current Assets	161	170	177	193	199	206	208	191	196	203	210	190	224	234	161	221	202	177	173	178	166	169	165	168	168	170	160	152	157	163	159	155	136	114	103	99	102	103	94	99
Cash	98	104	119	118	127	133	142	126	82	89	96	69	103	157	66	117	104	96	95	97	91	94	90	91	88	86	80	65	71	69	69	63	62	56	53	53	58	57	41	38
Cash & Short-Term Investments	120	125	139	143	153	157	163	139	149	159	167	141	173	185	92	144	125	98	95	97	91	94	90	91	88	86	80	65	71	69	69	63	62	56	53	53	58	57	41	38
Receivables	22	28	21	30	24	24	18	23	21	21	18	23	24	23	28	24	23	24	27	29	32	30	29	32	34	35	31	37	35	26	32	34	28	24	22	24	22	24	26	29
Inventory	18	16	16	18	20	22	23	24	24	21	23	23	25	22	35	46	48	46	43	43	35	36	35	35	37	40	41	43	44	24	49	51	40	24	21	17	16	19	23	29
Property, Plant & Equipment	51	52	52	52	54	56	56	55	55	54	53	53	52	51	54	53	52	51	49	71	49	48	48	80	78	48	49	48	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	7.7	7.2	7.3	7.8	8.1	8.2	8.5	8.0	8.0	7.9	7.7	7.8	7.5	7.7	34	34	32	8.4	8.0	8.1	8.0	7.8	7.6	7.2	6.7	7.3	7.5	7.5	7.3	7.6	7.4	7.4	7.7	7.1	7.4	8.1	8.1	8.1	7.9	7.8
Intangible Assets	11	10	10	11	11	11	11	9.9	9.6	9.2	8.5	8.3	7.7	7.6	99	96	94	91	89	87	85	82	80	78	77	75	73	71	69	2.6	4.3	4.0	3.1	2.5	2.3	1.7	1.7	1.7	1.7	1.7
Total Liabilities	17	17	17	21	20	19	21	19	14	15	38	36	38	42	105	152	132	93	86	76	63	60	56	68	63	64	61	55	58	58	55	52	52	49	42	40	43	47	45	46
Current Liabilities	7.6	8.8	10	13	12	13	14	13	9.3	11	12	10	11	16	26	28	31	37	47	41	29	30	27	29	26	28	29	23	28	31	28	26	25	23	18	16	19	22	21	22
Short-Term Debt	0.1	0.0	–	–	–	–	–	–	–	–	1.1	1.1	1.1	1.1	1.7	1.7	1.6	1.6	1.6	1.5	1.5	1.7	1.7	1.9	1.9	2.1	2.1	2.1	2.1	1.8	2.1	2.3	2.3	1.9	1.9	1.8	1.7	2.1	1.9	–
Accounts Payable	1.9	2.3	6.1	5.5	5.2	6.7	6.2	5.1	2.5	3.1	3.6	2.3	2.7	3.8	9.9	6.2	6.8	9.0	8.7	8.1	7.9	7.6	7.4	8.2	8.4	9.1	8.9	7.9	8.3	6.2	10	10.0	6.8	5.6	5.3	4.8	4.7	6.0	6.3	6.2
Long-Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	22	22	–	–	–	50	25	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	215	223	230	244	253	263	264	247	255	264	269	251	282	288	294	288	284	272	277	287	290	287	286	286	285	286	278	274	270	212	209	210	180	154	148	148	147	143	134	137
Retained Earnings	160	168	173	185	191	200	193	203	211	218	223	232	241	245	251	244	237	221	224	231	231	226	223	220	216	211	200	198	191	128	124	123	94	72	67	63	60	61	56	59
Shares Outstanding	15	15	15	15	15	15	15	15	14	14	14	14	14	15	14	14	14	14	14	15	15	14	14	15	15	15	15	15	15	15	15	15	15	15	14	14	14	15	14	13

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings